In order to counter such stigma and discrimination, women living with HIV and Hepatitis B came together at The Voice of ...
The Spanish government has today announced a further € 1 million contribution to UNAIDS to support its work to end AIDS by ...
This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...
There was a huge backlash,” remembered Dr Nittaya Phanuphak, the Executive Director of the Institute of HIV Research and Innovation (IHRI). She was telling the story from IHRI’s sunlit offices to ...
unaids.org UNAIDS There are around 1.4 million people living with HIV in China and women make up around 23.
New long-acting technologies are changing the HIV prevention landscape. In recent years, innovation in pre-exposure prophylaxis (PrEP) has accelerated. Long acting injectable cabotegravir and the ...